Effects of Dehydroepiandrosterone on the Response of Ovarian Stimulation During In Vitro Fertilization Cycle in Infertile Women With Diminished Ovarian Reserve: Before and After Clinical Trials

Objectives: The use of dehydroepiandrosterone (DHEA) before initiating in vitro fertilization (IVF) cycles to increase the ovarian reserve is considered as one of the best therapies in women with diminished ovarian reserve (DOR). Therefore, the present study aimed to compare the effect of DHEA on wo...

Full description

Bibliographic Details
Main Authors: Marzieh Zamaniyan, Bahar Farshidfar, Sepideh Peyvandi, Hamed Jafarpour, Robabeh Taheripanah, Siavash Moradi, Mojtaba Ghorbani
Format: Article
Language:English
Published: Aras Part Medical International Press 2019-07-01
Series:Crescent Journal of Medical and Biological Sciences
Subjects:
Online Access:http://www.cjmb.org/pdf.php?id=251
_version_ 1818047709948411904
author Marzieh Zamaniyan
Bahar Farshidfar
Sepideh Peyvandi
Hamed Jafarpour
Robabeh Taheripanah
Siavash Moradi
Mojtaba Ghorbani
author_facet Marzieh Zamaniyan
Bahar Farshidfar
Sepideh Peyvandi
Hamed Jafarpour
Robabeh Taheripanah
Siavash Moradi
Mojtaba Ghorbani
author_sort Marzieh Zamaniyan
collection DOAJ
description Objectives: The use of dehydroepiandrosterone (DHEA) before initiating in vitro fertilization (IVF) cycles to increase the ovarian reserve is considered as one of the best therapies in women with diminished ovarian reserve (DOR). Therefore, the present study aimed to compare the effect of DHEA on women (below and above 35 years old) with DOR and to find if this therapy is useful at an earlier age. Materials and Methods: This clinical trial study was conducted on 35 infertile women with DOR who referred to Imam Khomeini hospital in Sari, Iran, during 2017. The intervention lasted for 6 weeks and DHEA tablets were used before the start of the intra-cytoplasmic sperm injection-embryo transfer (ICSI-ET) cycle. Antral follicular counts (AFCs) and the serum levels of anti-Mullerian hormone (AMH) were estimated before and after the intervention, followed by performing the ICSI. Finally, the changes in AMH levels and AFC, the number and quality of ovum and embryos and pregnancy, along with the rates of implantation and abortion were measured as well. Results: The mean AMH levels (P=0.02) and AFC (P<0.001) after DHEA consumption varied significantly from those before administering the DHEA, and the increase in the AFC was more significant in the age group under 35 years (P=0.03). In addition, these changes were more significant in body mass of less than 25 kg/m2 (P=0.04). Conclusions: In general, the supplementation of DHEA in women with insufficient ovarian capacity probably improves IVF prognosis and other parameters including AFC and AMH, especially in women under 35 years old. Further, based on different evidence, the probability of pregnancy occurrence in women is lower with increased body mass index (BMI).
first_indexed 2024-12-10T10:10:06Z
format Article
id doaj.art-41cb8469df6843439b1545d05fac0305
institution Directory Open Access Journal
issn 2148-9696
language English
last_indexed 2024-12-10T10:10:06Z
publishDate 2019-07-01
publisher Aras Part Medical International Press
record_format Article
series Crescent Journal of Medical and Biological Sciences
spelling doaj.art-41cb8469df6843439b1545d05fac03052022-12-22T01:53:08ZengAras Part Medical International PressCrescent Journal of Medical and Biological Sciences2148-96962019-07-0163361368cjmb-5044Effects of Dehydroepiandrosterone on the Response of Ovarian Stimulation During In Vitro Fertilization Cycle in Infertile Women With Diminished Ovarian Reserve: Before and After Clinical TrialsMarzieh Zamaniyan0Bahar Farshidfar1Sepideh Peyvandi2Hamed Jafarpour3Robabeh Taheripanah4Siavash Moradi5Mojtaba Ghorbani6Infertility Center, Department of Obstetrics and Gynecology, Mazandaran University of Medical Sciences, Sari, Iran.Student Research Committee, College of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.Infertility Center, Department of Obstetrics and Gynecology, Mazandaran University of Medical Sciences, Sari, Iran.Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Community Medicine Specialist, Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran.Department of Surgery, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.Objectives: The use of dehydroepiandrosterone (DHEA) before initiating in vitro fertilization (IVF) cycles to increase the ovarian reserve is considered as one of the best therapies in women with diminished ovarian reserve (DOR). Therefore, the present study aimed to compare the effect of DHEA on women (below and above 35 years old) with DOR and to find if this therapy is useful at an earlier age. Materials and Methods: This clinical trial study was conducted on 35 infertile women with DOR who referred to Imam Khomeini hospital in Sari, Iran, during 2017. The intervention lasted for 6 weeks and DHEA tablets were used before the start of the intra-cytoplasmic sperm injection-embryo transfer (ICSI-ET) cycle. Antral follicular counts (AFCs) and the serum levels of anti-Mullerian hormone (AMH) were estimated before and after the intervention, followed by performing the ICSI. Finally, the changes in AMH levels and AFC, the number and quality of ovum and embryos and pregnancy, along with the rates of implantation and abortion were measured as well. Results: The mean AMH levels (P=0.02) and AFC (P<0.001) after DHEA consumption varied significantly from those before administering the DHEA, and the increase in the AFC was more significant in the age group under 35 years (P=0.03). In addition, these changes were more significant in body mass of less than 25 kg/m2 (P=0.04). Conclusions: In general, the supplementation of DHEA in women with insufficient ovarian capacity probably improves IVF prognosis and other parameters including AFC and AMH, especially in women under 35 years old. Further, based on different evidence, the probability of pregnancy occurrence in women is lower with increased body mass index (BMI).http://www.cjmb.org/pdf.php?id=251dehydroepiandrosteroneovarian reserveanti-mullerian hormoneinfertility
spellingShingle Marzieh Zamaniyan
Bahar Farshidfar
Sepideh Peyvandi
Hamed Jafarpour
Robabeh Taheripanah
Siavash Moradi
Mojtaba Ghorbani
Effects of Dehydroepiandrosterone on the Response of Ovarian Stimulation During In Vitro Fertilization Cycle in Infertile Women With Diminished Ovarian Reserve: Before and After Clinical Trials
Crescent Journal of Medical and Biological Sciences
dehydroepiandrosterone
ovarian reserve
anti-mullerian hormone
infertility
title Effects of Dehydroepiandrosterone on the Response of Ovarian Stimulation During In Vitro Fertilization Cycle in Infertile Women With Diminished Ovarian Reserve: Before and After Clinical Trials
title_full Effects of Dehydroepiandrosterone on the Response of Ovarian Stimulation During In Vitro Fertilization Cycle in Infertile Women With Diminished Ovarian Reserve: Before and After Clinical Trials
title_fullStr Effects of Dehydroepiandrosterone on the Response of Ovarian Stimulation During In Vitro Fertilization Cycle in Infertile Women With Diminished Ovarian Reserve: Before and After Clinical Trials
title_full_unstemmed Effects of Dehydroepiandrosterone on the Response of Ovarian Stimulation During In Vitro Fertilization Cycle in Infertile Women With Diminished Ovarian Reserve: Before and After Clinical Trials
title_short Effects of Dehydroepiandrosterone on the Response of Ovarian Stimulation During In Vitro Fertilization Cycle in Infertile Women With Diminished Ovarian Reserve: Before and After Clinical Trials
title_sort effects of dehydroepiandrosterone on the response of ovarian stimulation during in vitro fertilization cycle in infertile women with diminished ovarian reserve before and after clinical trials
topic dehydroepiandrosterone
ovarian reserve
anti-mullerian hormone
infertility
url http://www.cjmb.org/pdf.php?id=251
work_keys_str_mv AT marziehzamaniyan effectsofdehydroepiandrosteroneontheresponseofovarianstimulationduringinvitrofertilizationcycleininfertilewomenwithdiminishedovarianreservebeforeandafterclinicaltrials
AT baharfarshidfar effectsofdehydroepiandrosteroneontheresponseofovarianstimulationduringinvitrofertilizationcycleininfertilewomenwithdiminishedovarianreservebeforeandafterclinicaltrials
AT sepidehpeyvandi effectsofdehydroepiandrosteroneontheresponseofovarianstimulationduringinvitrofertilizationcycleininfertilewomenwithdiminishedovarianreservebeforeandafterclinicaltrials
AT hamedjafarpour effectsofdehydroepiandrosteroneontheresponseofovarianstimulationduringinvitrofertilizationcycleininfertilewomenwithdiminishedovarianreservebeforeandafterclinicaltrials
AT robabehtaheripanah effectsofdehydroepiandrosteroneontheresponseofovarianstimulationduringinvitrofertilizationcycleininfertilewomenwithdiminishedovarianreservebeforeandafterclinicaltrials
AT siavashmoradi effectsofdehydroepiandrosteroneontheresponseofovarianstimulationduringinvitrofertilizationcycleininfertilewomenwithdiminishedovarianreservebeforeandafterclinicaltrials
AT mojtabaghorbani effectsofdehydroepiandrosteroneontheresponseofovarianstimulationduringinvitrofertilizationcycleininfertilewomenwithdiminishedovarianreservebeforeandafterclinicaltrials